LGL Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
LGL Partners's LLY Position: Q2 2026 in Review
LGL Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 1,293 shares — an estimated $1.19M sold.
LGL Partners first reported a position in LLY in Q1 2019 and held it in 25 quarters. The position peaked at $1.8M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- LGL Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- LGL Partners sold 1,293 Eli Lilly shares in Q2 2026, an estimated $1.19M.
- LGL Partners first reported a position in Eli Lilly in Q1 2019 and held it in 25 quarters.
- LGL Partners's Eli Lilly position peaked at $1.8M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.